Acquired and genetic factors influencing the penetrance of HFE haemochromatosis;Facteurs acquis et génétiques de modulation de la pénétrance de i'hémochromatose HFE

Bulletin de l'Academie Nationale de Medecine

Volumn 192, Issue 5, 2008, Pages 873-881

  Deugnier, Yves ^a   Bourgain, Catherine ^b   Mosser, Jean ^c  

^a PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c UNIVERSITÉ DE RENNES 1   (France)

Author keywords

Bone morphogenetic protein receptors; Hemochromatosis; Hepcidin; Homozygote

Indexed keywords

HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ARTICLE; GENETICS; HEMOCHROMATOSIS; HOMOZYGOTE; HUMAN; MUTATION; PHENOTYPE; RISK FACTOR;

HEMOCHROMATOSIS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HOMOZYGOTE; HUMANS; MEMBRANE PROTEINS; MUTATION; PHENOTYPE; RISK FACTORS;

EID: 65249151878     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0001-4079(19)32750-5     Document Type: Article

References (43)

1. DEUGNIER Y., BRISSOT P., LORÉAL O. - Iron and the liver: update 2008. J. Hepatol., 2008, 48, 5113-5123.
2. FINCH C. - Iron metabolism in hemochromatosis. J. Clin. Invest., 1949, 28, 780.
3. SIMON M., BOUREL M., FAUCHET R., GENETET B. - Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut, 1976, 17, 332-4.
4. SIMON M., BOUREL M., GENETET B., FAUCHET R.-Idiopathic hemochromatosis. Demonstration of recessive transmission and early detection by family HLA typing. N. Engl. J. M ed., 1977, 297, 1017-21.
5. FEDER J. N., GNTRKE A., THOMAS W., TSUCHINASHI Z., RUDDY D. A., BASAVA A. et al.-A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis [see comments]. Nat. Genet., 1996, 13, 399-408.
6. LORÉAL O., HAZIZA-PIGEON C., TROADEC M. B., DETIVAUD L., TURLIN B., COURSELAUD B. et al. - Hepcidin in iron metabolism. Curr. Protein. Pept. Sci, 2005, 6, 279-91.
7. PIETRANGELO A. - Non-HFE hemochromatosis. Hepatology, 2004, 39, 21-9.
8. MERRYWEATHER-CLARKE A. T., POINTON J. J., JOUANOLLE A. M., ROCHETTE J., ROBSON K. J. - Geography of HFE C282Y and H63D mutations. Genet. Test, 2000, 4, 183-98.
9. BRISSOT P., MOIRAND R., JOUANOLLE A. M., GUYADER D., LE GALL J. Y., DEUGNIER Y. et al. - A genotypic study of 217 unrelated probands diagnosed as "genetic hemochromatosis" on "classical" phenotypic criteria. J. Hepatol., 1999, 30, 588-93.
10. ANDERSON G. J., DARSHAN D., WILKINS S. J., FRAZER D. M. - Regulation of systemic iron homeostasis : how the body responds to changes in iron demand. Biomet al.s. 2007, 20, 665-74.
11. GANZ T. - Molecular control of iron transport. J. Am. Soc. Nephrol., 2007, 18, 394-400.
12. BRISSOT P., DE BELS F. - Current approaches to the management of hemochromatosis. Hematology, 2006, 36-41.
13. ADAMS P. O., REBOUSSIN D. M., BARTON J. C., MCLAREN C. E., ECKFELDT J. H., MCLAREN G. D. et al.-Hemochromatosis and iron-overload screening in a racially diverse population. N. Engl. J. M ed., 2005, 352, 1769-78.
14. ALLEN K. J., GURRIN L. C., CONSTANTINE C. C., OSBORNE N. J., DELATYCKI M. B., NICOLL A. J. et al. - Iron-overload-related disease in HFE hereditary hemochromatosis. N. Engl. J. M ed., 2008, 358, 221-30.
15. BEUTLER E., FELITTI V. J., KOZIOL J. A., HO N. J., GELBART T. - Penetrance of 845G-> A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet, 2002, 359, 211-8.
16. DEUGNIER Y., JOUANOLLE A. M., CHAPERON J., MOIRAND R., PITHOIS C, MEYER J. F. et al. - Gender-specific phenotypic expression and screening strategies in C282Y-linked haemochromatosis : a study of 9396 French people. Br. J. Haematol, 2002, 118, 1170-8.
17. OLYNYK J. K., CULLEN D. J., AQUTLIA S., ROSSI E., SUMMERVILLE L., POWELL L. W. - A population-based study of the clinical expression of the hemochromatosis gene. N. Engl J. M ed., 1999, 341, 718-24.
18. CADE J. E., MORETON J. A., O'HARA B., GREENWOOD D. C., MOOR J., BURLEY V. J. et al. - Diet and genetic factors associated with iron status in middle-aged women. Am. J. Clin. Nutr., 2005, 82, 813-20.
19. VAN DER A. D., PEETERS P. H., GROBBEE D. E., ROEST M., VOORBOJ H. A., VAN DER SCHOUW Y. T. - HFE genotypes and dietary heme iron : no evidence of strong gene-nutrient interaction on serum ferritin concentrations in middle-aged women. Nutr. Metab. Cardiovasc Dis., 2006, 16, 60-8.
20. KALTWASSER J. P., WERNER E., SCHALK K., HANSEN C, GOTTSCHALK R., SEIDL C - Clinical trial on the effect of regular tea drinking on iron accumulation in genetic haemochromatosis. Gut, 1998, 43, 699-704.
21. HARRISON-FINDIK D. D. - Role of alcohol in the regulation of iron metabolism. World J. Gastroenterol., 2007, 13, 4925-30.
22. DERTVAUD L., NEMETH E., BOUDJEMA K., TURLIN B., TROADEC M. B., LEROYER P. et al. - Hepcidin levels in humans are correlated with hepatic iron stores, hemoglobin levels, and hepatic function. Blood, 2005, 106, 746-8.
23. BARTON J. C., PRESTON B. L., MCD ONNELL S. M., ROTHENBERG B. E.-Severity of iron overload in hemochromatosis: effect of volunteer blood donation before diagnosis. Transfusion, 2001, 41, 123-9.
24. LAINE F., JOUANNOLLE A. M., MORCET J., BRIGAND A., POUCHARD M., LAFRAISE B. et al. - Phenotypic expression in detected C282Y homozygous women depends on body mass index. J. Hepatol, 2005, 43, 1055-9.
25. BEKRI S., GUAL P., ANTYR., LUCIANI N., DAHMAN M., RAMESH B. et al. - Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology, 2006, 131, 788-96.
26. LAINE F., DEUGNIER Y. - Increased Expression of Hepcidin in Obese Patients : Impact on Phenotypic Expression of Hemochromatosis and Pathophysiology of Dysmetabolic Iron Overload Syndrome. Gastroenterology, 2006, 131, 2028.
27. HUTCHINSON C, GEISSLER C. A., POWELL J. J., BOMFORD A.-Proton pump inhibitors suppress absorption of dietary non-haem iron in hereditary haemochromatosis. Gut, 2007, 56, 1291-5.
28. MOIRAND R., ADAMS P. C., BICHELER V., BRISSOT P., DEUGNIER Y.-Clinical features of genetic hemochromatosis in women compared with men. Ann. Intern. M ed., 1997, 127, 105-10.
29. BULAJ Z. J., AJIOKA R. S., PHILLIPS J. D., LASALLE B. A., JORDE L. B., GRIFFEN L. M. et al. - Disease-Related Conditions in Relatives of Patients with Hemochromatosis. N. Engl. J. M ed., 2000, 343, 1529-1535.
30. WHITING P. W., FLETCHER L. M., DIXON J. K., GOCHEE P., POWELL L. W., CRAWFORD D. H. - Concordance of iron indices in homozygote and heterozygote sibling pairs in hemochromatosis families : implications for family screening. J. Hepatol, 2002, 37, 309-14.
31. WHITFIELD J. B., CULLEN L. M., JAZWINSKA E. C., POWELL L. W., HEATH A. C., ZHU G. et al. - Effects of HFE C282Y and H63D polymorphisms and polygenic background on iron stores in a large community sample of twins. Am. J. Hum. Genet., 2000, 66, 1246-58.
32. BENSAID M., FRUCHON S., MAZERES C, BAHRAM S., ROTH M. P., COPPIN H. - Multigenic control of hepatic iron loading in a murine model of hemochromatosis. Gastroenterology, 2004, 126, 1400-8.
33. LIVESEY K. J., WIMHURST V. L., CARTER K., WORWOOD M., CADET E., ROCHETTE J. et al. -The 16189 variant of mitochondrial DNA occurs more frequently in C282Y homozygotes with haemochromatosis than those without iron loading. J. Med. Genet., 2004, 41, 6-10.
34. BEUTLER E., BEUTLER L., LEE P. L., BARTON J. C.-The mitochondrial nt 16189 polymorphism and hereditary hemochromatosis. Blood Cells Mol. Dis., 2004, 33, 344-5.
35. LE GAC G., SCOTET V., KA C, GOURLAOUEN I., BRYCKAERT L., JACOLOT S. et al.-The recently identified type 2A juvenile haemochromatosis gene (HJV), a second candidate modifier of the C282Y homozygous phenotype. Hum. Mol. Genet., 2004, 13, 1913-8.
36. JACOLOT S., LE GAC G., SCOTET V., QUERE I., MURA C, FEREC C. - HAMP as a modifier gene that increases the phenotypic expression of the HFE pC282Y homozygous genotype. Blood, 2004, 103, 2835-40.
37. MERRYWEATHER-CLARKE A. T., CADET E., BOMFORD A., CAPRON D., VIPRAKASIT V., MILLER A. et al. - Digenic inheritance of mutations in HAMP and HFE results in different types of haemochromatosis. Hum. Mol. Genet., 2003, 12, 2241-7.
38. MILET J., DEHAIS V., BOURGAIN C, JOUANOLLE A. M., MOSSER A., PERRIN M. et al.-Common Variants in the BMP2, BMP4, and HJV Genes of the Hepcidin Regulation Pathway Modulate HFE Hemochromatosis Penetrance. Am. J. Hum. Genet., 2007, 81, 799-807.
39. FLETCHER L. M., DIXON J. L., PURDIE D. M., POWELL L. W., CRAWFORD D. H. - Excess alcohol greatly increases the prevalence of cirrhosis in hereditary hemochromatosis. Gastroenterology, 2002, 122, 281-9.
40. LORÉAL O., DEUGNIER Y., MOIRAND R., LAUVIN L., GUYADER D., JOUANOLLE H. et al. - Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients. J. Hepatol., 1992, 16, 122-7.
41. POWELL E. E., ALI A., CLOUSTON A. D., DIXON J. L., LINCOLN D. J., PURDIE D. M. et al. - Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology, 2005, 129, 1937-43.
42. OSTERREICHER C. H., DATZ C, STICKEL F., HELLERBRAND C, PENZ M., HOFER H. et al. - TGF-bet al. codon 25 gene polymorphism is associated with cirrhosis in patients with hereditary hemochromatosis. Cytokine, 2005, 31, 142-8.
43. VALENTI L., CONTE D., PIPERNO A., DONGIOVANNI P., FRACANZANI A. L., FRAQUELLI M. et al. - The mitochondrial superoxide dismutase A16V polymorphism in the cardiomyopathy associated with hereditary haemochromatosis. J. Med. Genet., 2004, 41, 946-50.